Stefan Zastrow
Publications by Year
Research Areas
Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, Renal and related cancers, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study(2019)334 cited
- → Systemic therapy in metastatic renal cell carcinoma(2016)229 cited
- → Vaccination of hormone‐refractory prostate cancer patients with peptide cocktail‐loaded dendritic cells: Results of a phase I clinical trial(2006)125 cited
- → Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma(2006)114 cited
- → CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastases(2011)113 cited
- → Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)(2012)105 cited
- → Dendritic Cell‐Based Immunotherapy for Prostate Cancer(2010)90 cited
- → Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer(2014)86 cited
- → Direct comparison of multiparametric magnetic resonance imaging ( MRI ) results with final histopathology in patients with proven prostate cancer in MRI /ultrasonography‐fusion biopsy(2016)71 cited
- → Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE ( AUO‐AB 31/05)(2013)68 cited